ImClone Photos

BioPharmaceutical Laboratory

+ Add Photo

ImClone Reviews

30 Reviews
30 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
(no image)
Jerry Kinzel
2 Ratings

    Wonderful learning opportunity!

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Intern in New York, NY
    Current Employee - Intern in New York, NY

    I have been working at ImClone as an intern (less than a year)


    Wonderful staff, always something new to learn, and opportunities to move up. I really enjoyed working with this company and would do it again.


    After being bought by Lilly, the community aspect lessened. Morale also decreased. However, this is only known if you worked there before the takeover. The company is still great after acquisition just not as awesome as it used to be.

    Positive Outlook
    No opinion of CEO

ImClone Interviews

Updated Dec 28, 2014
Updated Dec 28, 2014

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    Research Associate Interview

    Anonymous Employee
    Anonymous Employee
    Application Details

    I applied online. The process took a dayinterviewed at ImClone.

    Interview Details

    The itinerary and directions were emailed to me, I had communicated with HR back and forth using both email and phone. When I arrived onsite, the person greeting me was on time. The interview went according to schedule.

    Interview Questions
    • the most difficult question to answer was "why was I looking to leave my current job": I was not actively looking (pretty content, but when the opportunity came up I just decided to give it a try).   Answer Question
    Reasons for Declining

    The pay at the time was non-negotiable

    Declined Offer
    Positive Experience
    Average Interview

ImClone Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters Bridgewater, NJ
Size 1000 to 5000 Employees
Operated By Eli Lilly
Founded 1984
Type Subsidiary or Business Segment
Industry Biotech & Pharmaceuticals
Revenue $100 to $500 million (USD) per year

ImClone Systems wants to create identically successful cancer drug candidates. The company, a subsidiary of Eli Lilly, is focused on the development of oncology-related antibody therapies. The biotech research firm's only commercial product, Erbitux, is approved for treatment of colorectal cancer, as well as head and neck cancers. ImClone Systems co-promotes the drug with Bristol-Myers Squibb (BMS) in North America and with Merck KGaA elsewhere. The company is continuing to develop Erbitux as a possible treatment for other kinds of cancer, including lung cancer. It also... More

Work at ImClone? Share Your Experiences


Click to Rate